DiabetesLab is a Polish MedTech start-up founded in 2016.
The company offers an application that supports people with type 1 diabetes, helping them maintain stable blood glucose levels. The app specifically targets people who lead an active lifestyle — but it’s equally useful for any person with type 1 diabetes who wants to improve their health and well-being.
DLabs worked as a technical partner, taking responsibility for designing and developing the application up to the MVP stage in preparation for beta testing.
Studies estimate that 415 million people worldwide have diabetes. And experts predict that the number will increase to roughly 642 million by 2040.
In Poland alone, 2.9 million people have diabetes (type I and II), with one person dying every six seconds because of the disease: that’s roughly five million people-a-year — more than HIV, tuberculosis, and malaria, combined.
It’s very costly to treat diabetes. In 2018, the Polish National Health Fund spent 1.45 billion PLN delivering medication and testing slips to patients. At the same time, patients had to cover the additional treatment costs of 442 million PLN using personal funds.
A diabetes diagnosis is a life-changing moment for anyone, not least for those who are physically active. Diabetes has a drastic influence on lifestyle, and for anyone who’s newly diagnosed, it can be hard to adjust, confusing to plan a new diet, and stressful to manage the illness.
Przemysław Majewski, CEO of DLabs, is one such person struggling with diabetes. But he wanted to help other people with the disease manage the illness, plan a more balanced diet, and create personal training plans.
That’s why he created Suguard: the smartphone application that helps people with diabetes rediscover a balanced lifestyle.
Suguard is a comprehensive mobile application that uses state-of-the-art AI to personalize diabetic therapy and help patients in their everyday management of this chronic disease. It aims to predict and recommend actions to stabilize blood glucose levels, decreasing the risk of complications, thus reducing treatment costs.
The solution most benefits people who have type 1 diabetes: an illness that requires more intensive treatment and an exceptional level of personal care — in particular, during high-intensity physical activity.
Quick and easy to use
The app gets better every day, both technically and functionally. As people use it, the growing data-set helps the AI enhance its prediction capability and make more personalized recommendations. A handful of clients use Suguard daily — with every entry improving results for all users.
Suguard offers 90% efficiency in predicting actions that effectively stabilize blood glucose levels, decreasing the risk of complications while helping users choose the right foods, activities, and medicines.
Both the concept and the application have been recognized through media coverage and awards. One prize included one-year’s funding via the TechPeaks program: The People Accelerator in Italy.
The next step involves adapting the solution to the needs of patients with type 2 diabetes, alongside considering other potential illnesses. There are also plans to extend the AI solution to allow users to add natural inputs: for example, using voice commands.